Poster presented at ASBMB 2022

Presenter: Nigel Beaton
Monday, August 15

Poster 2924/9 presented at AACR 2022

Presenter: Yuehan Feng
Session: PO.CH02.01 – Structural and Chemical Biology
Date: April 12

Presenter: Fabio Mira Rocha Sabino

Date: Monday, June 5
Topic area: Drug Discovery: Qualitative and Quantitative Analysis I

At Biognosys, we believe that we can dramatically improve human health by deciphering the biological complexity of diseases. By providing access to the proteome on all levels, we enable life science researchers and drug hunters to unlock true discoveries.

We push the boundaries of what is possible with our proteomics solutions to help usher in a new age of bioengineering and precision medicine.

When we look at the proteome differently, we envision a better world!

To learn more about our vision, mission, and values, watch our new corporate video and visit: biognosys.com/our-story/

German life sciences magazine Transkript Laborwelt interviewed our Chief Business Officer Kristina Beeler, Ph.D., about the emerging wave of precision proteomics.

Read Full Magazine Issue (German language only)

Learn more about Biognosys’ proprietary TrueTarget™ platform in our latest brochure. This resource elaborates on how TrueTarget™ identifies the most promising and actionable drug targets to support your research.

Download Brochure

New: Spectronaut^® 19

Unlock Your Data's True Story

New: Spectronaut^® 19

Unlock Your Data's True Story

Learn More